Dechra Brings Laverdia® (Verdinexor Tablets), the First and Only FDA-Approved Oral Treatment for Dogs Diagnosed With Lymphoma
Merck Animal Health Highlights Landmark Clinical Research on Gilvetmab, the First Caninized Immune Checkpoint Inhibitor for Canine Oncology in the Journal of Veterinary Internal Medicine and Journal of the American Veterinary Medical Association
Boehringer Ingelheim’s New Quarterable Snap-Tab PREVICOX® (Firocoxib) Chewable Tablets Provide Flexible Dosing for Dogs in the U.S.
Animalcare Continues Partnership Drive With Principal Terms for Exclusive Global Licence Option for Long-Acting Injectable Technology
BiomEdit Acquires Folium Science Technology and Pipeline Assets to Expand Programmable Veterinary Biologics Capabilities
K‑State’s CEZID Awarded $11.4M in Continued NIH Funding to Advance Emerging and Zoonotic Infectious Disease Research